Therapeutic Phage Candidates for Targeting Prevalent Sequence Types of Carbapenem-Resistant Escherichia coli
Foodborne Pathogens and Disease · 2024-11 · 21 (11) · 681-688
DOI: 10.1089/fpd.2024.0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foodborne Pathogens and Disease, online erschienen am 07.11.2024. Verfasst von Md Shamsuzzaman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Multilocus Sequence Typing, Escherichia coli, Anti-Bacterial Agents, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Carbapenem-resistant Escherichia coli (CREC) is a global threat to public health; therefore, alternative treatment options are urgently needed. Bacteriophages have emerged as promising candidates for combating CREC infections. This study aimed to investigate the genetic basis of phage sensitivity in CREC by evaluating carbapenem resistance among multidrug-resistant (MDR) E. coli isolated in Daegu, South Korea and analyzing their sequence types (STs) with phage susceptibility spectra. Among the 60 MDR E. coli isolates, 80.4% were identified as CREC, with 77.0% demonstrating resistance to imipenem and 66.6% to meropenem. Moreover, 70 lytic E. coli bacteriophages were isolated from hospital sewage water and evaluated against those 60 E. coli isolates. The phages exhibited lytic activity of 33%–60%, with average titers ranging from 5.6 × 10 12 to 2.4 × 10 13 PFU/mL (Plaque-Forming Unit). Furthermore, multilocus sequence typing (MLST) analysis of the bacterial isolates revealed 14 distinct STs, mostly belonging to ST131, ST410, and ST648. Notably, the phage susceptibility spectra of ST73, ST13003, ST648, ST2311, ST167, ST405, ST607, ST7962, and ST131 were significantly different. Thus, the isolated phages can effectively lyse CREC isolates, particularly those with clinically dominant STs. Conversely, ST410 exhibited a 14.2%–87.14% susceptibility spectrum, whereas ST1139, ST1487, ST10, and ST206 did not lyse, suggesting the presence of more resistant STs. Future studies are warranted to identify the reasons behind this resistance and address it. Ultimately, this study will aid in developing focused treatments to address these pressing global health issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
- Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
ORCID-Profile: Md Shamsuzzaman
Zitieren
APA
Shamsuzzaman, M., Kim, S., Choi, Y. J., Kim, B., Dahal, R. H., Shin, M., & Kim, J. (2024). Therapeutic Phage Candidates for Targeting Prevalent Sequence Types of Carbapenem-Resistant Escherichia coli. Foodborne Pathogens and Disease, 21(11), 681-688. https://doi.org/10.1089/fpd.2024.0023
Vancouver
Shamsuzzaman M, Kim S, Choi YJ, Kim B, Dahal RH, Shin M, et al. Therapeutic Phage Candidates for Targeting Prevalent Sequence Types of Carbapenem-Resistant Escherichia coli. Foodborne Pathogens and Disease. 2024;21(11):681-688. doi:10.1089/fpd.2024.0023
BibTeX
@article{Shamsuzzaman2024,
author = {Shamsuzzaman, Md and Kim, Shukho and Choi, Yoon-Jung and Kim, Bokyung and Dahal, Ram Hari and Shin, Minsang and Kim, Jungmin},
title = {Therapeutic Phage Candidates for Targeting Prevalent Sequence Types of Carbapenem-Resistant Escherichia coli},
journal = {Foodborne Pathogens and Disease},
year = {2024},
volume = {21},
number = {11},
pages = {681--688},
doi = {10.1089/fpd.2024.0023}
}
EUVIMED